4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0001415889-25-010686
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lettmann Jason CHIEF EXECUTIVE OFFICER | 2025-04-11 | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | D | ||
Loading xslF345X05/form4-04152025_080459.xml…